10-90743617-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_019859.4(HTR7):c.1369C>T(p.Pro457Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_019859.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTR7 | NM_019859.4 | c.1369C>T | p.Pro457Ser | missense_variant | 3/4 | ENST00000336152.8 | NP_062873.1 | |
HTR7 | XM_024447973.2 | c.775C>T | p.Pro259Ser | missense_variant | 3/4 | XP_024303741.1 | ||
HTR7 | NM_000872.5 | c.1296-1089C>T | intron_variant | NP_000863.1 | ||||
HTR7 | NM_019860.4 | c.*2-1089C>T | intron_variant | NP_062874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTR7 | ENST00000336152.8 | c.1369C>T | p.Pro457Ser | missense_variant | 3/4 | 1 | NM_019859.4 | ENSP00000337949 | ||
HTR7 | ENST00000277874.10 | c.1296-1089C>T | intron_variant | 1 | ENSP00000277874 | A1 | ||||
HTR7 | ENST00000371719.2 | c.*2-1089C>T | intron_variant | 1 | ENSP00000360784 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251414Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135878
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461660Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727132
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at